Company Overview
About Alys Pharmaceuticals
Alys Pharmaceuticals, founded in 2023, is an innovative immuno-dermatology company with a team of experienced experts. With approximately 11 employees, the company is focused on developing transformative solutions to address unmet needs in dermatologic conditions. Alys has an R&D pipeline enabled by multi-platform technologies, including a phase IIa trial for a potential treatment for alopecia areata.
Frequently Asked Questions about Alys Pharmaceuticals
Technologies Used
Social Profiles
Key Decision Makers
Thibaud Portal Founder
Thibaud Portal Chief Executive Officer/Owner